Literature DB >> 9512922

Ab initio molecular modeling in the study of drug metabolism.

M D Segall1, M C Payne, S W Ellis, G T Tucker, R N Boyes.   

Abstract

We discuss the use of ab initio quantum mechanical methods in drug metabolism studies. These methods require only the positions and atomic numbers of the atoms to be specified and offer greater transferability than conventional molecular modeling techniques. This fact, coupled with the accuracy of our approach, permits 'computational experiments' to be performed, allowing details of reaction mechanisms to be understood. We review the application of these methods to the cytochrome P450 superfamily of enzymes. There is much interest in understanding the mechanisms of these enzymes due to their participation in a wide range of metabolic processes including drug activation/deactivation. We find that our methods accurately reproduce the low- to high-spin transition of the haem Fe on binding of a substrate. Furthermore, we identify a new mechanism for the suppression of this spin transition, namely the shortening of the bond between the Fe atom and the coordinated S atom of the cysteine axial ligand. These results indicate that ab initio molecular modeling may be usefully applied in the study of drug metabolism and that further study of intermediate states in the P450 reaction cycle would be beneficial, particularly those which are not accessible using conventional experimental approaches.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9512922     DOI: 10.1007/BF03190958

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Optimized and transferable nonlocal separable ab initio pseudopotentials.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1993-02-15

Review 2.  Cytochrome P450cam: crystallography, oxygen activation, and electron transfer.

Authors:  T L Poulos; R Raag
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

3.  An ab initio approach to the understanding of cytochrome P450-ligand interactions.

Authors:  M D Segall; M C Payne; S W Ellis; G T Tucker; R N Boyes
Journal:  Xenobiotica       Date:  1998-01       Impact factor: 1.908

4.  Computer modeling of 3D structures of cytochrome P450s.

Authors:  Y T Chang; O B Stiffelman; G H Loew
Journal:  Biochimie       Date:  1996       Impact factor: 4.079

5.  The structural basis for substrate-induced changes in redox potential and spin equilibrium in cytochrome P-450CAM.

Authors:  R Raag; T L Poulos
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

6.  Crystal structure of substrate-free Pseudomonas putida cytochrome P-450.

Authors:  T L Poulos; B C Finzel; A J Howard
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

7.  PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

Authors:  B Waszkowycz; D E Clark; D Frenkel; J Li; C W Murray; B Robson; D R Westhead
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

8.  Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation.

Authors:  R Raag; T L Poulos
Journal:  Biochemistry       Date:  1991-03-12       Impact factor: 3.162

9.  Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutants.

Authors:  R Mackman; R A Tschirret-Guth; G Smith; G P Hayhurst; S W Ellis; M S Lennard; G T Tucker; C R Wolf; P R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  1996-07-01       Impact factor: 4.013

10.  Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam.

Authors:  T L Poulos; A J Howard
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.